Based in Tampa, Florida, The Mosaic Company (MOS) produces and markets concentrated phosphate and potash crop nutrients for the global agricultural industry. Valued at a market cap of $7.6 billion, the company also provides nitrogen-based crop nutrients, animal feed ingredients, and other ancillary services.
Companies valued at less than $10 billion are generally considered “mid-cap” stocks, and Mosaic fits this criterion perfectly. The Mosaic Company’s leading position within the global fertilizer industry is supported by a diverse portfolio of high-quality products, including potash, phosphates, and micro-nutrients.
With a strong focus on innovation, sustainability, and operational efficiency, Mosaic has established a robust supply chain and distribution network that serves customers across key agricultural regions worldwide. Additionally, the company’s commitment to sustainable farming practices and its ability to leverage scale and market reach position it well for long-term growth in the evolving agricultural sector.
Shares of MOS are trading 16.3% below their 52-week high of $37.29, which they reached on Jan. 3. The agricultural chemical producer has declined 11.7% over the past three months, lagging behind the broader Nasdaq Composite ($NASX), which has soared 8.8% over the same time frame.
Over the past six months, MOS has fallen 19.1%, lagging behind NASX’s 10.4% gains. Moreover, shares of MOS have declined 34.7% over the past 52 weeks, significantly struggling to keep up with NASX’s 30.6% rally.
To confirm its bearish trend, MOS has been trading below its 200-day moving average since the past year and has remained below its 50-day moving average since mid-December.
On Nov. 12, shares of MOS plunged 7.7% after announcing its Q3 earnings report. It posted net sales of $2.8 billion, weaker than the consensus of $3.14 billion. Moreover, its EPS of $0.38 was also less than the projected estimate.
MOS’ has also underperformed its rival Nutrien Ltd. (NTR), which declined 22.9% over the past 52 weeks and 15.3% on a YTD basis.
Despite MOS’ underperformance, analysts remain moderately optimistic about its prospects. The stock has a consensus rating of “Moderate Buy” from 15 analysts in coverage, and the mean price target of $32.34 suggests a premium of nearly 35.5% to its current levels.
